Noveris Health Sciences Stock Price, News & Analysis
Company Description
Noveris Health Sciences (OTC Link: MYCOF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $247.5K.
MYCOF stock has gained 289.8% over the past year. Shares last traded at $1.32.
This page provides a comprehensive overview of MYCOF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Noveris Health Sciences (MYCOF) stock last traded at $1.32. Over the past 12 months, the stock has gained 289.8%. At a market capitalization of $247.5K, MYCOF is classified as a micro-cap stock with approximately 48.9M shares outstanding.
Latest News
Noveris Health Sciences has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, management, clinical trial. View all MYCOF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
MYCOF Company Profile & Sector Positioning
Noveris Health Sciences (MYCOF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing MYCOF often look at related companies in the same sector, including Canaquest Medica (CANQF), Real Brands (RLBD), Indoor Harvest (INQD), Branded Legacy Inc (BLEG), and Lowell Farms (LOWLF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MYCOF's relative position within its industry.